ES2039460T3 - Un procedimiento para producir una solucion inyectable de glicosido de antraciclina. - Google Patents

Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.

Info

Publication number
ES2039460T3
ES2039460T3 ES198787310632T ES87310632T ES2039460T3 ES 2039460 T3 ES2039460 T3 ES 2039460T3 ES 198787310632 T ES198787310632 T ES 198787310632T ES 87310632 T ES87310632 T ES 87310632T ES 2039460 T3 ES2039460 T3 ES 2039460T3
Authority
ES
Spain
Prior art keywords
anthracicline
glycoside
procedure
producing
injectable solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787310632T
Other languages
English (en)
Spanish (es)
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Roberto De Ponti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26291656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2039460(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868629193A external-priority patent/GB8629193D0/en
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2039460T3 publication Critical patent/ES2039460T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES198787310632T 1986-12-05 1987-12-03 Un procedimiento para producir una solucion inyectable de glicosido de antraciclina. Expired - Lifetime ES2039460T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629193A GB8629193D0 (en) 1986-12-05 1986-12-05 Injectable ready-to-use solutions
US6465387A 1987-06-22 1987-06-22

Publications (1)

Publication Number Publication Date
ES2039460T3 true ES2039460T3 (es) 1993-10-01

Family

ID=26291656

Family Applications (3)

Application Number Title Priority Date Filing Date
ES91102986T Expired - Lifetime ES2082023T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.
ES198787310632T Expired - Lifetime ES2039460T3 (es) 1986-12-05 1987-12-03 Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
ES95101919T Expired - Lifetime ES2198424T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para el empleo que contienen doxorrubicina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES91102986T Expired - Lifetime ES2082023T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95101919T Expired - Lifetime ES2198424T3 (es) 1986-12-05 1987-12-03 Soluciones inyectables listas para el empleo que contienen doxorrubicina.

Country Status (22)

Country Link
EP (4) EP0438183B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2621255B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (2) KR0158672B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1058391C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (2) ATE129896T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU632036B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE1000540A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH680494A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (4) DE3752368T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK175815B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES2082023T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI91710C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2607702B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2200047B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (2) GR871846B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (2) HK39591A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1226072B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8702914A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO175802C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT86285B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE512881C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG36591G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
CA2446837C (en) * 2001-05-11 2012-01-03 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
WO2006085336A2 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
JP2008513519A (ja) * 2005-05-11 2008-05-01 シコール インコーポレイティド 安定した凍結乾燥されたアントラサイクリングリコシド
CN101795694B (zh) * 2007-09-04 2012-10-10 明治制果药业株式会社 注射剂、注射液和注射用试剂盒制剂
EP2174651A1 (en) * 2008-10-09 2010-04-14 Charité-Universitätsmedizin Berlin (Charité) A polymer-free hydrogel
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2187311B (en) * 1984-07-27 1988-02-10 Ae Plc Automatic vehicle speed control system
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH0655667A (ja) * 1992-08-06 1994-03-01 Nippon Zeon Co Ltd 複合成形体

Also Published As

Publication number Publication date
EP1283044A3 (en) 2003-05-14
GB2200047A (en) 1988-07-27
FR2607702A1 (fr) 1988-06-10
DE3777365D1 (de) 1992-04-16
PT86285B (pt) 1990-11-07
KR960007861B1 (ko) 1996-06-13
BE1000540A5 (fr) 1989-01-24
HK1049440A1 (en) 2003-05-16
EP0273603A2 (en) 1988-07-06
AU8205987A (en) 1988-06-09
GR871846B (en) 1988-04-01
NO875055D0 (no) 1987-12-03
EP0659435B1 (en) 2003-05-14
FI875340L (fi) 1988-06-06
DK175815B1 (da) 2005-03-07
EP0438183B1 (en) 1995-11-08
SG36591G (en) 1991-06-21
NO875055L (no) 1988-06-06
DE3751589D1 (de) 1995-12-14
DE3751589T2 (de) 1996-05-02
GR3004303T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-31
DE3752368T2 (de) 2004-02-12
CN87108225A (zh) 1988-09-14
SE512881C2 (sv) 2000-05-29
JPS63215633A (ja) 1988-09-08
FI91710B (fi) 1994-04-29
KR880007086A (ko) 1988-08-26
PT86285A (en) 1988-01-01
CN1058391C (zh) 2000-11-15
EP0273603B1 (en) 1992-03-11
FI875340A0 (fi) 1987-12-03
IT1226072B (it) 1990-12-10
EP1283044A2 (en) 2003-02-12
GB2200047B (en) 1990-11-21
ATE240108T1 (de) 2003-05-15
IT8722869A0 (it) 1987-12-03
GB8728313D0 (en) 1988-01-06
EP0659435A1 (en) 1995-06-28
HK1011288A1 (en) 1999-07-09
ES2198424T3 (es) 2004-02-01
DE3752368D1 (de) 2003-06-18
HK39591A (en) 1991-05-31
FI91710C (fi) 1994-08-10
JP2621255B2 (ja) 1997-06-18
EP0273603A3 (en) 1988-07-20
NO175802B (no) 1994-09-05
SE8704849L (sv) 1988-06-06
EP0438183A1 (en) 1991-07-24
SE8704849D0 (sv) 1987-12-03
FR2607702B1 (fr) 1991-08-16
NL8702914A (nl) 1988-07-01
DE3741037A1 (de) 1988-06-09
AU632036B2 (en) 1992-12-17
DK635287A (da) 1988-06-06
ES2082023T3 (es) 1996-03-16
KR0158672B1 (en) 1998-12-01
DK635287D0 (da) 1987-12-03
ATE129896T1 (de) 1995-11-15
CH680494A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-09-15
NO175802C (no) 1994-12-14

Similar Documents

Publication Publication Date Title
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
DK275488A (da) Indolonderivater
ES2181723T3 (es) Formulaciones farmaceuticas de factor de crecimiento nervioso.
MY101207A (en) Treatment of diseases caused by retroviruses
ES2078238T3 (es) Esteres tiocromanicos de fenoles y tereftalatos que tienen actividad similar a la de los retinoides.
ES2087061T3 (es) Utilizacion de ribosido o ribotido de aica para la fabricacion de un medicamento contra la crisis cardiaca o el infarto de miocardio en los pacientes que sufren de ateroesclerosis.
DE3167687D1 (en) Nutrient solution for complete extra-buccal feeding and for an enhanced production of energy, and manufacturing process
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2036221T3 (es) Procedimiento para preparar una composicion de l-dopa de dosis unitaria multiple.
ES2039460T3 (es) Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
ES2196000T3 (es) Compuesto de pirroloazepina.
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
AR016382A1 (es) Uso de un derivado del acido bencil-indazol metoxialcanoico.
ES2067206T3 (es) Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria.
KR910009270A (ko) 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법
MX9300638A (es) Derivados del acido aminobenzoico.
CO4930262A1 (es) Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica
ES2151891T3 (es) Derivados de ciclohexano sustituidos con imidazolilo.
GB1460325A (en) Pharmaceutical composition intended for relieving pain and producing analgesia
ES8504182A1 (es) Procedimiento para preparar nuevos derivados de piperidina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 273603

Country of ref document: ES